Device verification samples for MT-RNR1 (POCT) – 3 SET
Three sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 4 SET
Four sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 5 SET
Five sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Pharmacogenetics (DPYD / UGT1A1 only)
DPYD and/or UGT1A1 pharmacogenetic testing for drug response and efficacy (Germline DNA).
Pharmacogenetics (panel testing)
Pharmacogenetic panel testing of markers for drug response and efficacy (Germline DNA).
CYP2C19 POCT
Point-of-care molecular testing (POCT) of CYP2C19 for optimisation of antiplatelet therapy (Artificial Buccal swabs)